戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 ccording to the Sepsis-3 definitions, 1231 patients (14.1%) were classified as having sepsis and had a mortality rate of
2    Of 2044 MR imaging studies in the diagnostic group, 1443 were classified as having low BPE and 601 were classified as
3 e proposed TNM groupings, 1797 of the 3315 patients (54.2%) were classified as stage I, 684 (20.6%) as stage II, 669 (20.
4 ents were using a self-administered systemic therapy; 22.4% were classified as "non-adherent" (12% intentionally and 10.9
5         Of 9241 patients in 11 cohort studies, 2825 (30.6%) were classified as low risk.
6 ostic group, 1443 were classified as having low BPE and 601 were classified as having high BPE (71% vs 29%, respectively;
7  to those reported in previous studies; 55 patients (35.7%) were classified as having depression, and 32 patients (20.8%)
8  as disabled based on NEI VFQ-25 results, whereas 169 (72%) were classified as nondisabled.
9                     One hundred eighty-seven patients (92%) were classified as indeterminate, while the remaining 17 pati
10 f these, only 8 (10%) samples were microscopic positive and were classified as pfhrp2-deleted.
11                                                       Cases were classified as having early or late tears using a segment
12                                                      Donors were classified as no AKI, or AKI stage 1-3 according to Acut
13                                           Pleural effusions were classified as exudates or transudates according to the L
14 lation, high chromatin accessibility and H3K9ac enrichment, were classified as enhancer candidates.
15 CH1/FBXW7 (N/F) mutations and RAS/PTEN (R/P) germ line (GL) were classified as oncogenetic low risk (gLoR; n = 111), wher
16                      Based on annual TAVR volume, hospitals were classified as low (<50), medium (>/=50 to <100), and hig
17                                                 Individuals were classified as "highly affected," "mildly affected," and
18                                             Exposure levels were classified as increased based on percentile (75th/90th)
19 e with N/F GL and R/P GL mutations or N/F and R/P mutations were classified as high risk (gHiR; n = 109).
20                                               The mutations were classified as pathogenic, likely pathogenic, likely beni
21                                               The observers were classified as having a low level of experience (<500 sca
22                                                Participants were classified as having normal (A-) or abnormal (A+) amyloi
23                                    58 (12%) of participants were classified as high-risk; the probability of having non-d
24                                                    Patients were classified as "perfect reporters" (self-report agreed wi
25                                                    Patients were classified as "target mismatch" if they had a small isch
26                                                    Patients were classified as having THV thrombosis if there was any evi
27                                                    Patients were classified as HER2-positive (HER2+) or -negative (HER2-)
28                                                    Patients were classified as phenotype-positive (n=72) or phenotype-neg
29 IT D816V expressed allele burden (EAB) at month 6, patients were classified as KIT responders (>/=25%, n = 17) or KIT non
30 enting 44 centers in the United States and Europe, patients were classified as having had CED or a combined end point of
31              At baseline, 67 of 236 (28%) glaucoma patients were classified as disabled based on NEI VFQ-25 results, wher
32                             Endocardial activation patterns were classified as chaotic (varying cycle lengths and nonsync
33                                     The MRI growth patterns were classified as nodular or diffuse.
34                                                       PDACs were classified as conventional (51%), combined with a predom
35 s assigned to BIIB074 versus nine (64%) assigned to placebo were classified as treatment failures (p=0.0974).
36                                                     Results were classified as definitely positive scan findings versus p
37                                                Five studies were classified as high quality, two were moderate quality, n
38                                                    Subjects were classified as having poor, intermediate, or ideal cardio
39                                                    Subjects were classified as presumed NAFLD (pNF; alanine aminotransfer
40 lassified as normal based on cluster criteria on 24-2 tests were classified as abnormal on 10-2 visual fields.
41                                  Of these 9 lesions, 3 that were classified as infiltrative on MRI exhibited stage I infi
42 trative histologic growth patterns; of the remaining 6 that were classified as nodular by MRI, 5 histologically demonstra
43                    Material/Seventy-nine breast masses that were classified as BI-RADS category 3, 4, and 5 on B-mode ult
44 w many complex spikes emerged during learned swimming, they were classified as multiple, single, or zero complex spike (M
45 ausality assessment by established guidelines, six variants were classified as "pathogenetic/likely pathogenetic" and two
46                                       Tibial artery vessels were classified as completely occluded, significantly stenose
47                                 White matter lesions (WMLs) were classified as "active" (DVR highest in the lesion), "per
48                                                       Women were classified as TFI cases or controls based on laparoscopi
49 ith proximal (clinical AL) progression >/=3 mm over 5 years were classified as having disease progression.
50 xteen patients (11 women, 5 men; mean age, 39+/-17.2 years) were classified as having definite (n=13) or probable (n=3) D

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。